Machine Learning for the Prediction of Amyloid Positivity in Amnestic Mild Cognitive Impairment
- Authors
- Kang, S.H.; Cheon, B.K.; Kim, J.-S.; Jang, H.; Kim, H.J.; Park, K.W.; Noh, Y.; Lee, J.S.; Ye, B.S.; Na, D.L.; Lee, H.; Seo, S.W.
- Issue Date
- Mar-2021
- Publisher
- IOS PRESS
- Keywords
- amnestic mild cognitive impairment; Aβ PET; Aβ positivity; machine learning; magnetic resonance imaging features; neuropsychological tests; prediction model
- Citation
- JOURNAL OF ALZHEIMERS DISEASE, v.80, no.1, pp.143 - 157
- Journal Title
- JOURNAL OF ALZHEIMERS DISEASE
- Volume
- 80
- Number
- 1
- Start Page
- 143
- End Page
- 157
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/80632
- DOI
- 10.3233/JAD-201092
- ISSN
- 1387-2877
- Abstract
- BACKGROUND: Amyloid-β (Aβ) evaluation in amnestic mild cognitive impairment (aMCI) patients is important for predicting conversion to Alzheimer's disease. However, Aβ evaluation through Aβ positron emission tomography (PET) is limited due to high cost and safety issues. OBJECTIVE: We therefore aimed to develop and validate prediction models of Aβ positivity for aMCI using optimal interpretable machine learning (ML) approaches utilizing multimodal markers. METHODS: We recruited 529 aMCI patients from multiple centers who underwent Aβ PET. We trained ML algorithms using a training cohort (324 aMCI from Samsung medical center) with two-phase modelling: model 1 included age, gender, education, diabetes, hypertension, apolipoprotein E genotype, and neuropsychological test scores; model 2 included the same variables as model 1 with additional MRI features. We used four-fold cross-validation during the modelling and evaluated the models on an external validation cohort (187 aMCI from the other centers). RESULTS: Model 1 showed good accuracy (area under the receiver operating characteristic curve [AUROC] 0.837) in cross-validation, and fair accuracy (AUROC 0.765) in external validation. Model 2 led to improvement in the prediction performance with good accuracy (AUROC 0.892) in cross validation compared to model 1. Apolipoprotein E genotype, delayed recall task scores, and interaction between cortical thickness in the temporal region and hippocampal volume were the most important predictors of Aβ positivity. CONCLUSION: Our results suggest that ML models are effective in predicting Aβ positivity at the individual level and could help the biomarker-guided diagnosis of prodromal AD.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/80632)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.